KALA BIO INC
COM NEW · CUSIP 483119202
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 1 |
| Q4 2022 | 28 |
| Q1 2023 | 25 |
| Q2 2023 | 28 |
| Q3 2023 | 26 |
| Q4 2023 | 25 |
| Q1 2024 | 29 |
| Q2 2024 | 29 |
| Q3 2024 | 27 |
| Q4 2024 | 33 |
| Q1 2025 | 28 |
| Q2 2025 | 29 |
| Q3 2025 | 22 |
| Q4 2025 | 29 |
| Q1 2026 | 27 |
| Q2 2026 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2024 | 7 | 11 |
| Q4 2024 | 14 | 8 |
| Q1 2025 | 13 | 12 |
| Q2 2025 | 11 | 9 |
| Q3 2025 | 14 | 13 |
| Q4 2025 | 14 | 11 |
| Q1 2026 | 13 | 10 |
| Q2 2026 | 0 | 27 |
Biggest buyers
| None |
Biggest sellers
| RENAISSANCE TECHNOLOGIES LLC | Sold out | -417.5k |
| CITADEL ADVISORS LLC | Sold out | -281.6k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -261.1k |
| Virtu Financial LLC | Sold out | -152.2k |
| ADAR1 Capital Management, LLC | Sold out | -141.5k |
| GSA CAPITAL PARTNERS LLP | Sold out | -84.5k |
| UBS Group AG | Sold out | -66.9k |
| VANGUARD CAPITAL MANAGEMENT LLC | Sold out | -60.5k |
| JANE STREET GROUP, LLC | Sold out | -36.0k |
| JPMORGAN CHASE & CO | Sold out | -30.0k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| OXFORD FINANCE LLC 13G · exempt (held before listing) new · filed 2025-12-03 | 16.5% |
| BAKER BROS. ADVISORS LP 13G · institution no change · filed 2026-02-17 | 10.0% |
| LIFESCI CAPITAL, LLC 13G · institution new · filed 2026-01-13 | 7.9% |
Lazar David E.
13D · may seek influence
new · filed 2026-02-06
Stated purposePursuant to the SPA, as further described in Item 6, effective as of November 23, 2025, the Reporting Person was appointed as the Chief Executive Officer and a member of the Issuer's Board of Directors. In addition to the Reporting Person being appointed as a director and Chief Executive Officer of the Issuer, pursuant to the SPA, the Reporting Person will have the right to recommend to the Issuer up to eight (8) individuals to be nominated for election at the Issuer's upcoming stockholder meeting (the "Stockholder Meeting"), subject to stockholder approval and compliance with Nasdaq Listing Rule 5640. Upon his election to the Board, the Reporting Person will serve as the Chairman of the Board. The Reporting Person purchased the Shares pursuant to the SPA based on the Reporting Person's … Full filing |
5.2% |
Fell to 5% or below in the last year: PERCEPTIVE ADVISORS LLC (0.0%, 2025-11-14), Cormorant Asset Management, LP (0.0%, 2025-11-14), Point72 Asset Management, L.P. (0.0%, 2025-11-14)
Holders, Q2 2026
| Manager | Shares | Change |
|---|